Efficacy, long-term survival and safety of different PD-1 inhibitors plus chemotherapy in recurrent or metastatic nasopharyngeal carcinoma: a systematic review and meta-analysis - Quiz - MDSpire

Efficacy, long-term survival and safety of different PD-1 inhibitors plus chemotherapy in recurrent or metastatic nasopharyngeal carcinoma: a systematic review and meta-analysis

  • By

  • Wen Sun

  • Yansha Liu

  • Hui Dong

  • Yun Huang

  • June 15, 2026

  • 0 min

Share

Original Source(s)

Efficacy, long-term survival and safety of different PD-1 inhibitors plus chemotherapy in recurrent or metastatic nasopharyngeal carcinoma: a systematic review and meta-analysis

  • by Wen Sun, Yansha Liu, Hui Dong, Yun Huang

  • June 15, 2026

Related Content

HK2 knockdown is associated with context-dependent inflammatory and angiogenesis-related transcriptional programmes in glioblastoma cells

Waldenström macroglobulinemia-associated renal AL amyloidosis: a case report and literature review

Detection of MEN1 resistance mutations in cell-free DNA from acute leukemia patients treated with menin inhibitors